Taken together, these features support the hypothesis that the PPAR pathway might harbour anti-neoplastic targets in endometrial cancer, which is known to be promoted by obesity and hyperinsulinaemia [5]. Here, PPARA is linked to obesity due to melanocortin 4 receptor deficiency.